Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03276494 · ClinicalTrials.gov registry record · Phase 2
Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access
A Phase 2 study of Stroke and Cerebral Edema, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT03276494: Completed Phase 2 study of Stroke and Cerebral Edema, sponsored by Ohio State University.
NCT03276494 is a Phase 2 study of Stroke and Cerebral Edema that has completed, run by Ohio State University. The registered enrollment target is 6 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03276494, a Phase 2 study of Stroke and Cerebral Edema, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypertonic saline is used to treat elevated intracranial pressure. Intraosseous vascular access has been used to administer fluids and medications. This study combines these to administer 3% hypertonic saline via IO.
Primary Outcome
Number of subjects with tissue damage (e.g. Myonecrosis, Skin necrosis, Extravasation, Compartment syndrome, Osteomyelitis). These data points will be determined by clinician assessment.
Conditions Studied
Interventions
- DRUG Hypertonic saline
- DEVICE Intraosseous
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-04-21 |
| Est. Completion | 2018-04-21 |
| Phase | Phase 2 |
What the finished NCT03276494 record still lists
NCT03276494 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Hypertonic saline is the first listed.
NCT03276494 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03276494 about?
NCT03276494 is a clinical study titled "Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access". Hypertonic saline is used to treat elevated intracranial pressure. Intraosseous vascular access has been used to administer fluids and medications. This study combines these to administer 3% hypertonic saline via IO.
What is the current status of trial NCT03276494?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2017-04-21. Estimated completion is 2018-04-21.
What conditions does trial NCT03276494 study?
This clinical trial studies the following conditions: Stroke, Cerebral Edema, Intracranial Hypotension.
What interventions are being tested in trial NCT03276494?
The interventions under investigation include: Hypertonic saline (DRUG), Intraosseous (DEVICE).
Who is sponsoring clinical trial NCT03276494?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03276494 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03276494's enrollment target sits among peer trials
6 433rd of 454 higher than 17 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
RECRUITING · Phase 2
-
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia
RECRUITING · Phase 2
-
Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia
RECRUITING · Phase 2
-
Myofascial Dysfunction in Post Stroke Shoulder Pain
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI